328 related articles for article (PubMed ID: 22792354)
1. In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis.
Kazenwadel J; Secker GA; Betterman KL; Harvey NL
PLoS One; 2012; 7(7):e40497. PubMed ID: 22792354
[TBL] [Abstract][Full Text] [Related]
2. The β
Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
[TBL] [Abstract][Full Text] [Related]
3. Modulation of VEGF-induced migration and network formation by lymphatic endothelial cells: Roles of platelets and podoplanin.
Langan SA; Navarro-Núñez L; Watson SP; Nash GB
Platelets; 2018 Jul; 29(5):486-495. PubMed ID: 28727496
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
7. TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides.
Bauer J; Rothley M; Schmaus A; Quagliata L; Ehret M; Biskup M; Orian-Rousseau V; Jackson DG; Pettis RJ; Harvey A; Bräse S; Thiele W; Sleeman JP
J Mol Med (Berl); 2018 Feb; 96(2):199-209. PubMed ID: 29282520
[TBL] [Abstract][Full Text] [Related]
8. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
9. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Lala PK; Nandi P; Majumder M
Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
[TBL] [Abstract][Full Text] [Related]
10. Equine Endothelial Cells Show Pro-Angiogenic Behaviours in Response to Fibroblast Growth Factor 2 but Not Vascular Endothelial Growth Factor A.
Finding EJT; Faulkner A; Nash L; Wheeler-Jones CPD
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892205
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
12. TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin.
James JM; Nalbandian A; Mukouyama YS
Development; 2013 Sep; 140(18):3903-14. PubMed ID: 23946447
[TBL] [Abstract][Full Text] [Related]
13. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
García-Caballero M; Blacher S; Paupert J; Quesada AR; Medina MA; Noël A
Br J Pharmacol; 2016 Jun; 173(12):1966-87. PubMed ID: 27018653
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis.
Shin JW; Huggenberger R; Detmar M
Blood; 2008 Sep; 112(6):2318-26. PubMed ID: 18614759
[TBL] [Abstract][Full Text] [Related]
15. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.
Maertens L; Erpicum C; Detry B; Blacher S; Lenoir B; Carnet O; Péqueux C; Cataldo D; Lecomte J; Paupert J; Noel A
PLoS One; 2014; 9(9):e106976. PubMed ID: 25222747
[TBL] [Abstract][Full Text] [Related]
17. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
19. CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells.
Tan YZ; Wang HJ; Zhang MH; Quan Z; Li T; He QZ
J Cell Mol Med; 2014 Mar; 18(3):422-33. PubMed ID: 24450475
[TBL] [Abstract][Full Text] [Related]
20. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
